Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1788-08-5 | MDL No. : | MFCD11040256 |
Formula : | C8H7NO2S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | OQPUCENNUFNCQO-UHFFFAOYSA-N |
M.W : | 181.21 | Pubchem ID : | 44457221 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 45.37 |
TPSA : | 68.54 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.91 cm/s |
Log Po/w (iLOGP) : | 1.35 |
Log Po/w (XLOGP3) : | 0.7 |
Log Po/w (WLOGP) : | 1.48 |
Log Po/w (MLOGP) : | 0.88 |
Log Po/w (SILICOS-IT) : | 0.56 |
Consensus Log Po/w : | 0.99 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.71 |
Solubility : | 3.55 mg/ml ; 0.0196 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.72 |
Solubility : | 3.48 mg/ml ; 0.0192 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.04 |
Solubility : | 1.63 mg/ml ; 0.00902 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.0 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
62% | With tetrabutyl ammonium fluoride In tetrahydrofuran at 20℃; | [0477] To a solution OF 4- [ (TRIMETHYLSILYL) ETHYNYL] BENZENESULFONAMIDE prepared as in Step 1 (1.69 g, 3.13 mmole) in anhydrous THF under A N2 atmosphere was added TBAF (10 mL-1.0 M in THF, 10 mmole) and the resulting mixture was stirred at room temperature. When silica TLC (1: 1 hexanes: EtOAc) indicated the reaction was complete, 10percent HC1 and EtOAc were added. The EtOAc layer was separated, washed twice with H20, aqueous NH4C1, dried over NA2S04 and concentrated IN VACUO to give 0. 748 g (62percent yield) of the product: ESHRMS M/Z 199.0506 (M+NH4, CGH7NO2SNH4, Calc'd 199. 0541). |
1.5 g | With tetrabutyl ammonium fluoride In tetrahydrofuran at 20℃; for 2 h; | The crude intermediate 1 was treated with TBAF in THF (20 mL. 20 mmol) and stirred for 2 hours at r.t. then quenched by water and extracted with EtOAc (50 mL x 2). The combine organic layer was dried over anhydrous Na2SO4 concentrated to give crude intermediate 2 which was purified by column chromatography to give pure intermediate 2 (1.5 g, 84percent) as yellow solid. |
1.5 g | With tetrabutyl ammonium fluoride In tetrahydrofuran at 20℃; for 2 h; | The crude intermediate 1 was treated with TBAF in THF (20 mL, 20 mmol) and stirred for 2 h at r.t., then quenched by water and extracted with EtOAc (50 mL×2). The combine organic layer was dried over anhydrous Na2SO4, concentrated to give crude intermediate 2, which was purified by column chromatography to give pure intermediate 2 (1.5 g, 84percent) as yellow solid. 1H NMR (300 MHz, DMSO-d6) δ7.82 (d, 2H), 7.68 (d, 2H), 7.46 (s, 2H), 4.45 (s, |
[ 188447-91-8 ]
(S)-4-Methylbenzenesulfinamide
Similarity: 0.82
[ 10447-10-6 ]
4-Methylnaphthalene-1-sulfonamide
Similarity: 0.80
[ 6292-59-7 ]
4-(tert-Butyl)benzenesulfonamide
Similarity: 0.80
[ 340771-31-5 ]
1-Ethynyl-4-(methylsulfonyl)benzene
Similarity: 0.65
[ 1349199-60-5 ]
3-Ethynyl-1-tosylazetidin-3-ol
Similarity: 0.57
[ 188447-91-8 ]
(S)-4-Methylbenzenesulfinamide
Similarity: 0.82
[ 10447-10-6 ]
4-Methylnaphthalene-1-sulfonamide
Similarity: 0.80
[ 6292-59-7 ]
4-(tert-Butyl)benzenesulfonamide
Similarity: 0.80
[ 10447-10-6 ]
4-Methylnaphthalene-1-sulfonamide
Similarity: 0.80
[ 6292-59-7 ]
4-(tert-Butyl)benzenesulfonamide
Similarity: 0.80